search icon
cpix-img

Cumberland Pharmaceuticals Inc, Common Stock

CPIX

NSQ

$2.67

+$0.34

(14.59%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$37.49M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
7.46M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.22
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.04 L
$3.05 H
$2.67

About Cumberland Pharmaceuticals Inc, Common Stock

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameCPIXSectorS&P500
1-Week Return12.66%0.31%-1.26%
1-Month Return25.94%0.6%-4.16%
3-Month Return103.82%-9.44%-0.46%
6-Month Return82.88%-5.15%3.58%
1-Year Return36.92%0.33%22.47%
3-Year Return-33.08%4.53%25.13%
5-Year Return-47.95%35.98%77.7%
10-Year Return-55.13%100.72%190.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue34.39M37.44M35.99M42.01M39.55M[{"date":"2019-12-31","value":81.86,"profit":true},{"date":"2020-12-31","value":89.12,"profit":true},{"date":"2021-12-31","value":85.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.15,"profit":true}]
Cost of Revenue7.42M8.65M8.81M9.12M6.07M[{"date":"2019-12-31","value":81.39,"profit":true},{"date":"2020-12-31","value":94.89,"profit":true},{"date":"2021-12-31","value":96.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.53,"profit":true}]
Gross Profit26.97M28.79M27.17M32.89M33.49M[{"date":"2019-12-31","value":80.53,"profit":true},{"date":"2020-12-31","value":85.97,"profit":true},{"date":"2021-12-31","value":81.15,"profit":true},{"date":"2022-12-31","value":98.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin78.42%76.89%75.51%78.29%84.66%[{"date":"2019-12-31","value":92.63,"profit":true},{"date":"2020-12-31","value":90.82,"profit":true},{"date":"2021-12-31","value":89.19,"profit":true},{"date":"2022-12-31","value":92.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses36.26M35.17M34.85M38.60M43.04M[{"date":"2019-12-31","value":84.23,"profit":true},{"date":"2020-12-31","value":81.71,"profit":true},{"date":"2021-12-31","value":80.97,"profit":true},{"date":"2022-12-31","value":89.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(9.29M)(6.38M)(7.68M)(5.70M)(6.21M)[{"date":"2019-12-31","value":-928818200,"profit":false},{"date":"2020-12-31","value":-638159500,"profit":false},{"date":"2021-12-31","value":-767742000,"profit":false},{"date":"2022-12-31","value":-570492900,"profit":false},{"date":"2023-12-31","value":-621081900,"profit":false}]
Total Non-Operating Income/Expense(5.64K)(376.56K)2.04M(363.85K)(491.15K)[{"date":"2019-12-31","value":-0.28,"profit":false},{"date":"2020-12-31","value":-18.43,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-17.81,"profit":false},{"date":"2023-12-31","value":-24.04,"profit":false}]
Pre-Tax Income(9.29M)(6.57M)(5.56M)(5.58M)(6.28M)[{"date":"2019-12-31","value":-929100400,"profit":false},{"date":"2020-12-31","value":-656987700,"profit":false},{"date":"2021-12-31","value":-556223000,"profit":false},{"date":"2022-12-31","value":-558118900,"profit":false},{"date":"2023-12-31","value":-628499700,"profit":false}]
Income Taxes(79.32K)55.90K34.89K68.85K45.77K[{"date":"2019-12-31","value":-115.2,"profit":false},{"date":"2020-12-31","value":81.19,"profit":true},{"date":"2021-12-31","value":50.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":66.48,"profit":true}]
Income After Taxes(9.21M)(6.63M)(5.60M)(5.65M)(6.33M)[{"date":"2019-12-31","value":-921168800,"profit":false},{"date":"2020-12-31","value":-662577900,"profit":false},{"date":"2021-12-31","value":-559712100,"profit":false},{"date":"2022-12-31","value":-565003900,"profit":false},{"date":"2023-12-31","value":-633076600,"profit":false}]
Income From Continuous Operations(3.55M)(6.63M)(5.60M)(5.65M)(2.49M)[{"date":"2019-12-31","value":-354651100,"profit":false},{"date":"2020-12-31","value":-662577900,"profit":false},{"date":"2021-12-31","value":-559712100,"profit":false},{"date":"2022-12-31","value":-565003900,"profit":false},{"date":"2023-12-31","value":-248849300,"profit":false}]
Income From Discontinued Operations3.21M3.21M1.99M--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":62.19,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(9.21M)(6.63M)(5.60M)(5.65M)(6.28M)[{"date":"2019-12-31","value":-921168800,"profit":false},{"date":"2020-12-31","value":-662577900,"profit":false},{"date":"2021-12-31","value":-559712100,"profit":false},{"date":"2022-12-31","value":-565003900,"profit":false},{"date":"2023-12-31","value":-627932000,"profit":false}]
EPS (Diluted)0.310.12(0.18)(0.26)(0.15)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":38.71,"profit":true},{"date":"2021-12-31","value":-58.06,"profit":false},{"date":"2022-12-31","value":-83.87,"profit":false},{"date":"2023-12-31","value":-49.71,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CPIX
Cash Ratio 0.56
Current Ratio 1.13
Quick Ratio 0.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CPIX
ROA (LTM) -5.64%
ROE (LTM) -36.07%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CPIX
Debt Ratio Lower is generally better. Negative is bad. 0.68
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.32

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CPIX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.89
P/B 1.32
Price/FCF 75
EV/R 1.00
EV/Ebitda 106.32
PEG NM

FAQs

What is Cumberland Pharmaceuticals Inc share price today?

Cumberland Pharmaceuticals Inc (CPIX) share price today is $2.67

Can Indians buy Cumberland Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Cumberland Pharmaceuticals Inc (CPIX) on Vested. To buy Cumberland Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CPIX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cumberland Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Cumberland Pharmaceuticals Inc (CPIX) via the Vested app. You can start investing in Cumberland Pharmaceuticals Inc (CPIX) with a minimum investment of $1.

How to invest in Cumberland Pharmaceuticals Inc shares from India?

You can invest in shares of Cumberland Pharmaceuticals Inc (CPIX) via Vested in three simple steps:

  • Click on Sign Up or Invest in CPIX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cumberland Pharmaceuticals Inc shares
What is Cumberland Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Cumberland Pharmaceuticals Inc (CPIX) is $3.05. The 52-week low price of Cumberland Pharmaceuticals Inc (CPIX) is $1.04.

What is Cumberland Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cumberland Pharmaceuticals Inc (CPIX) is

What is Cumberland Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cumberland Pharmaceuticals Inc (CPIX) is 1.32

What is Cumberland Pharmaceuticals Inc dividend yield?

The dividend yield of Cumberland Pharmaceuticals Inc (CPIX) is 0.00%

What is the Market Cap of Cumberland Pharmaceuticals Inc?

The market capitalization of Cumberland Pharmaceuticals Inc (CPIX) is $37.49M

What is Cumberland Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Cumberland Pharmaceuticals Inc is CPIX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top